Aehr Test Systems Stock Drops Amid Vicor's Positive Guidance
Aehr Test Systems' stock fell 7.58% to $13.80 per share, crossing below the 20-day SMA, despite positive signals from Vicor's revenue guidance raise.
The stock's decline comes amid Vicor's unexpected increase in second-quarter revenue guidance, which reflects strong demand for AI infrastructure that indirectly benefits Aehr Test Systems. However, despite the positive market sentiment, Aehr's stock price has dropped, indicating a potential sector rotation or profit-taking by investors following recent gains. Additionally, Aehr's recent order of $41 million from a leading hyperscaler and total orders exceeding $92 million for the second half of fiscal 2026 highlight its growth potential, but challenges in achieving profitability remain a concern.
Investors are closely monitoring the developments in the AI infrastructure sector, as continued demand could lead to further order growth for Aehr. However, the current price movement suggests caution as the market adjusts to the latest news.
Trade with 70% Backtested Accuracy
Analyst Views on AEHR
About AEHR
About the author

- Stock Surge: Aehr Test Systems' stock surged 16.2% to $14.94 per share this afternoon, reflecting market optimism about its growth prospects, particularly against the backdrop of strong demand in the AI infrastructure sector.
- Vicor Guidance Raise: Vicor unexpectedly raised its second-quarter revenue guidance, driven by rising product revenues and royalties from an additional licensee of its patented power system technology, indicating accelerating demand for data center power solutions that indirectly benefits Aehr's market outlook.
- Order Explosion: Aehr recently secured a $41 million order from its lead hyperscaler customer, pushing its total orders for the second half of fiscal 2026 to over $92 million, significantly exceeding its previous guidance of $60 million to $80 million, highlighting strong demand for its testing equipment.
- Profitability Outlook: Although Aehr is a couple of years away from profitability, the ongoing growth in orders will bolster investor confidence, and if Vicor's positive signals continue, Aehr may receive more orders in the future, further solidifying its position in the AI data center market.
- Strong Demand Signal: Vicor's unexpected second-quarter revenue guidance increase indicates rising demand for AI infrastructure, positively impacting Aehr Test Systems, which saw its stock price soar by 16.2%.
- Orders Exceed Expectations: Aehr Test Systems reported over $92 million in orders for the second half of fiscal 2026, significantly surpassing its previous guidance of $60 million to $80 million, highlighting its robust growth potential in the AI infrastructure sector.
- Expanding Customer Base: Aehr recently secured a $41 million order from a leading hyperscaler, further solidifying its position in the power semiconductor and AI processor testing equipment market, suggesting potential for continued order growth.
- Profitability Challenges: Despite significant order growth, Aehr faces challenges in achieving profitability, which is crucial for bolstering investor confidence and ensuring sustainable development in a competitive market.
- Aehr Test Systems Performance: Aehr Test Systems (AEHR) has seen its stock price soar 379% year-to-date and an astonishing 961% over the past year, reflecting strong demand for its AI chip testing equipment, particularly in data centers and electric vehicles, which is likely to continue attracting investor interest.
- Backlog Fuels Growth: The company reported in its Q3 FY2026 earnings that it only generated $10 million in revenue in Q1 but booked $37 million in future business, and later secured a $41 million contract from a major client, boosting total bookings to approximately $92 million, indicating robust market demand.
- ServiceNow's Challenges and Opportunities: ServiceNow (NOW) has faced a 42% decline in stock price this year, yet it achieved a 22% year-over-year revenue growth and beat earnings expectations in Q1, despite short-term pressures from delayed contracts in the Middle East, with an expected subscription guidance increase to 22% to 22.5% for 2026, showcasing its long-term growth potential.
- Market Outlook and Analyst Ratings: Despite short-term profitability challenges, ServiceNow's remaining performance obligations stand at $27.7 billion, representing a 25% year-over-year growth, and with 90% of analysts rating it a buy and a median price target of $137.50, suggesting a 57% upside, indicating strong market confidence in its future performance.
- Outstanding Market Performance: Aehr Test Systems has seen its stock price soar by 327% in 2026, significantly outperforming competitors like Nvidia, Broadcom, and AMD, indicating strong demand and leadership in the semiconductor testing equipment market.
- Significant Order Growth: The company reported a total of $92 million in bookings, including a record $41 million production order from a hyperscaler customer, highlighting its expanding market share in data center testing.
- Optimistic Financial Outlook: Although revenue for the most recent quarter was around $10 million, Aehr anticipates fiscal year 2026 revenue between $45 million and $50 million, reflecting strong order backlogs and future growth potential.
- Analysts Favor Long-Term Prospects: Despite the current stock being viewed as overvalued, analysts remain optimistic about Aehr's long-term outlook, projecting a 71% revenue growth in fiscal 2027 and an increase in earnings from a net loss of $0.09 per share to $0.15 per share.
- Stock Performance: Aehr Test Systems has seen its stock price surge 327% year-to-date in 2026, reflecting strong demand for its semiconductor testing equipment amid the AI boom.
- Market Leadership: Aehr is recognized as a leader in wafer-level testing, and despite facing competition from international players, it continues to grow its market share in EV and data center testing, with an increasing revenue contribution from data centers.
- Order Growth: The company reported expected annual revenue between $45 million and $50 million, along with $37 million in bookings, indicating robust market demand and significant growth potential ahead.
- Analyst Outlook: While the current stock price is viewed as overvalued, analysts remain optimistic about Aehr's long-term prospects, forecasting a 71% revenue growth in fiscal 2027 and an increase in earnings per share from a net loss of $0.09 to $0.15 this fiscal year.
- Stock Surge: Aehr Test Systems' shares skyrocketed by 144.2% in April 2026, indicating a doubling of stock price within a month, reflecting strong market confidence in the company's future growth prospects.
- Backlog Growth: By the end of Q3 2026, Aehr's backlog of unfilled orders reached $38.7 million, significantly up from $18.2 million a year ago, providing robust support for future revenues and indicating strong market demand.
- Historic Order: On April 16, Aehr secured its largest order ever, a $41 million follow-on order from an existing hyperscale customer, with revenue-generating shipments expected to commence in fiscal year 2027, further driving revenue growth.
- Market Trend Impact: Despite reporting net losses and sales below expectations in Q3 2026, investors remain optimistic about Aehr's strong order growth in the semiconductor sector, reflecting confidence in the company's future development.











